Ocera Therapeutics Inc (OCRX.OQ)

OCRX.OQ on NASDAQ Stock Exchange Global Market

4.94USD
5 Mar 2015
Change (% chg)

$-0.06 (-1.20%)
Prev Close
$5.00
Open
$5.00
Day's High
$5.01
Day's Low
$4.90
Volume
20,866
Avg. Vol
22,216
52-wk High
$16.98
52-wk Low
$4.66

OCRX.OQ

Chart for OCRX.OQ

About

Ocera Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is focused on the development and commercialization of a clinical candidate, OCR-002, for the treatment of hepatic encephalopathy (HE). OCR-002 is ornithine phenylacetate, which functions as an ammonia scavenger. OCR-002 lowers ammonia in... (more)

Overall

Beta: 2.45
Market Cap(Mil.): $111.54
Shares Outstanding(Mil.): 19.74
Dividend: --
Yield (%): --

Financials

  OCRX.OQ Industry Sector
P/E (TTM): -- 38.99 40.21
EPS (TTM): -2.62 -- --
ROI: -63.94 17.01 16.34
ROE: -63.95 17.53 17.27
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks